The arrival of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication suggests to offer significant improvements in fat reduction compared to previous therapies. Preliminary research tri… Read More